- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 311/24 - Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
Patent holdings for IPC class C07C 311/24
Total number of patents in this class: 24
10-year publication summary
|
1
|
0
|
1
|
2
|
3
|
2
|
1
|
0
|
3
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| E. I. du Pont de Nemours and Company | 3777 |
3 |
| The Scripps Research Institute | 1343 |
3 |
| Academic Pharmaceuticals Incorporated | 10 |
2 |
| Baylor College of Medicine | 983 |
2 |
| Modernatx, Inc. | 1280 |
2 |
| The Texas a & M University System | 1799 |
2 |
| Bayer Pharma AG | 1036 |
1 |
| FUJIFILM Corporation | 30010 |
1 |
| DSM IP Assets B.V. | 5479 |
1 |
| Abbvie Inc. | 1820 |
1 |
| Chugai Seiyaku Kabushiki Kaisha | 1387 |
1 |
| Geistlich Pharma AG | 162 |
1 |
| Nektar Therapeutics | 432 |
1 |
| N.V. Organon | 522 |
1 |
| Shanghai East Hospital | 8 |
1 |
| Calico Life Sciences LLC | 104 |
1 |
| Other owners | 0 |